Yong Yang

Copper-aspirin complex inhibits cyclooxygenase-2 more selectively than aspirin.

Zhiqiang Shen, Y. Yun, W. Duan, 2007, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

COVID-19 and metabolic comorbidities: An update on emerging evidences for optimal therapies

X. Rong, D. Ye, Kaixuan Yan, 2021, Biomedicine & Pharmacotherapy.

In vitro inhibition and induction of human liver cytochrome P450 enzymes by gentiopicroside: potent effect on CYP2A6.

Wen-ji Sun, Xueying Liu, Yating Deng, 2013, Drug metabolism and pharmacokinetics.

Elucidation of mechanisms of action of Wei-Sheng-Fang-Yi-Bao-Dan in the treatment of COVID-19 and depression using network pharmacology and molecular docking

Haicheng Han, Xiao-qing Fu, Dan Wang, 2022, Tropical Journal of Pharmaceutical Research.